[SFGate] Costly hepatitis C drugs could add $300 to every American’s yearly premium, CVS says

Gilead Sciences’ new hepatitis C drug receives as much praise for its healing powers as it receives criticism of its price, $84,000 for 12 weeks. Those parallel storylines played out even further in a prominent scientific journal’s latest edition, published online over the weekend.

[button title=”Read More” link=”http://blog.sfgate.com/techchron/2014/07/21/costly-hepatitis-c-drugs-could-add-300-to-every-americans-yearly-premium-cvs-says/” target=”_blank” size=”” color=”” class=””]